UBS Group’s Prenetics Global Ltd Warrant PRENW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10 Sell
566
-580
-51% -$13 ﹤0.01% 10329
2025
Q4
$34 Buy
1,146
+119
+12% +$3 ﹤0.01% 10306
2025
Q3
$26 Buy
1,027
+461
+81% +$14 ﹤0.01% 10105
2025
Q2
$22 Hold
566
﹤0.01% 10115
2025
Q1
$6 Sell
566
-3,996
-88% -$47 ﹤0.01% 10138
2024
Q4
$37 Sell
4,562
-22,433
-83% -$251 ﹤0.01% 9731
2024
Q3
$297 Buy
26,995
+26,429
+4,669% +$304 ﹤0.01% 9015
2024
Q2
$8 Buy
566
+233
+70% +$2 ﹤0.01% 9374
2024
Q1
$2 Hold
333
﹤0.01% 9187
2023
Q4
$2 Sell
333
-31,336
-99% -$473 ﹤0.01% 9191
2023
Q3
$1.27K Buy
+31,669
New +$1.85K ﹤0.01% 8013
2022
Q4
Sell
-4,830
Closed -$2K 11045
2022
Q3
$2K Buy
4,830
+599
+14% +$190 ﹤0.01% 9763
2022
Q2
$1K Buy
+4,231
New +$1.58K ﹤0.01% 9932

Other funds holding PRENW

UBS Group's PRENW Position: Q1 2026 in Review

UBS Group reduced its Prenetics Global Ltd Warrant (PRENW) stake by 51% in Q1 2026, selling an estimated $13 and leaving 566 shares worth $10. The position accounts for ﹤0.01% of the portfolio, ranked #10329.

UBS Group first reported a position in PRENW in Q2 2022 and has held it in 13 quarters since. The position peaked at $2K in Q3 2022. 13 funds tracked by Wall St. Rank hold PRENW as of Q1 2026.

  • UBS Group held 566 shares of Prenetics Global Ltd Warrant worth $10 as of Q1 2026.
  • UBS Group sold 580 Prenetics Global Ltd Warrant shares in Q1 2026, an estimated $13.
  • Prenetics Global Ltd Warrant made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #10329 holding.
  • UBS Group first reported a position in Prenetics Global Ltd Warrant in Q2 2022 and has held it in 13 quarters since.
  • UBS Group's Prenetics Global Ltd Warrant position peaked at $2K in Q3 2022.
  • 13 funds tracked by Wall St. Rank held Prenetics Global Ltd Warrant as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.